BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

831 related articles for article (PubMed ID: 17182410)

  • 1. GQ1b antibody testing in Guillain-Barre syndrome and variants.
    Chaudhry F; Gee KE; Vaphiades MS; Biller J; Jay W
    Semin Ophthalmol; 2006; 21(4):223-7. PubMed ID: 17182410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a.
    Tatsumoto M; Koga M; Gilbert M; Odaka M; Hirata K; Kuwabara S; Yuki N
    J Neuroimmunol; 2006 Aug; 177(1-2):201-8. PubMed ID: 16844234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bickerstaff's brainstem encephalitis: clinical features of 62 cases and a subgroup associated with Guillain-Barré syndrome.
    Odaka M; Yuki N; Yamada M; Koga M; Takemi T; Hirata K; Kuwabara S
    Brain; 2003 Oct; 126(Pt 10):2279-90. PubMed ID: 12847079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Miller-Fisher syndrome and the spectrum of oculomotor palsies with anti-GQ1b antibodies].
    Schabet M
    Klin Monbl Augenheilkd; 2010 Nov; 227(11):857-9. PubMed ID: 21077017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-GQ1b IgG antibody syndrome: clinical and immunological range.
    Odaka M; Yuki N; Hirata K
    J Neurol Neurosurg Psychiatry; 2001 Jan; 70(1):50-5. PubMed ID: 11118247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical correlates of serum anti-GT1a IgG antibodies.
    Nagashima T; Koga M; Odaka M; Hirata K; Yuki N
    J Neurol Sci; 2004 Apr; 219(1-2):139-45. PubMed ID: 15050449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolated ptosis as acute ophthalmoplegia without ataxia, positive for anti-GQ1b immunoglobulin G.
    Jindal G; Parmar VR; Gupta VK
    Pediatr Neurol; 2009 Dec; 41(6):451-2. PubMed ID: 19931169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute ophthalmoplegia (without ataxia) associated with anti-GQ1b antibody.
    Lee SH; Lim GH; Kim JS; Oh SY; Kim JK; Cha JK; Yun CH; Kang JK; Lee H; Song HK; Chung KC
    Neurology; 2008 Aug; 71(6):426-9. PubMed ID: 18678825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
    Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
    Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anti-GQ1b IgG-negative case of overlapping Fisher's and Gullain-Barré syndromes after Campylobacter jejuni (PEN 19) enteritis].
    Hayashi Y; Koga M; Takahashi M; Uchida A; Yuki N
    Rinsho Shinkeigaku; 2001 Nov; 41(11):801-4. PubMed ID: 12080613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of relapsing Guillain-Barré syndrome following Miller Fisher syndrome].
    Mochizuki A; Ota K; Iijima M; Yamauchi T; Iwata M
    Rinsho Shinkeigaku; 1996 May; 36(5):675-9. PubMed ID: 8905988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoglobulins inhibit pathophysiological effects of anti-GQ1b-positive sera at motor nerve terminals through inhibition of antibody binding.
    Jacobs BC; O'Hanlon GM; Bullens RW; Veitch J; Plomp JJ; Willison HJ
    Brain; 2003 Oct; 126(Pt 10):2220-34. PubMed ID: 12876146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and immunological spectrum of the Miller Fisher syndrome.
    Lo YL
    Muscle Nerve; 2007 Nov; 36(5):615-27. PubMed ID: 17657801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical relevance of the determination of anti-GQ1b antibodies in Miller Fisher and Guillain-Barré syndromes.
    Goffette S; Jeanjean A; Pierret F; Peeters A; Sindic CJ
    Acta Neurol Belg; 1998 Dec; 98(4):322-6. PubMed ID: 9922819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of testing kits of anti-ganglioside antibody: clinical utility in Guillain-Barré and Fisher syndromes].
    Akiyama M; Koga M; Yoshino H; Hamaoka A; Noguchi Y; Hirata K; Yuki N
    No To Shinkei; 2006 Jun; 58(6):477-81. PubMed ID: 16856515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical spectrum of the anti-GQ1b antibody syndrome: a case series of eight patients.
    de Bruyn A; Poesen K; Bossuyt X; Heremans IP; Claeys T; Depuydt CE; Van Damme P; Claeys KG
    Acta Neurol Belg; 2019 Mar; 119(1):29-36. PubMed ID: 30747336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of bacterial strains to clinical syndromes of Campylobacter-associated neuropathies.
    Kimoto K; Koga M; Odaka M; Hirata K; Takahashi M; Li J; Gilbert M; Yuki N
    Neurology; 2006 Nov; 67(10):1837-43. PubMed ID: 17130419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ataxic Guillain-Barré syndrome with anti-GQ1b antibody: relation to Miller Fisher syndrome.
    Yuki N; Susuki K; Hirata K
    Neurology; 2000 May; 54(9):1851-3. PubMed ID: 10802797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ganglioside complexes containing GQ1b as targets in Miller Fisher and Guillain-Barre syndromes.
    Kanzaki M; Kaida K; Ueda M; Morita D; Hirakawa M; Motoyoshi K; Kamakura K; Kusunoki S
    J Neurol Neurosurg Psychiatry; 2008 Oct; 79(10):1148-52. PubMed ID: 18339728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Miller Fisher's syndrome.
    Teener JW
    Semin Neurol; 2012 Nov; 32(5):512-6. PubMed ID: 23677659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.